This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Haberkorn, U. Articles by Altmann, A. Search for Related Content Social Bookmarking                         What's this?

Imaging Techniques for Gene Therapy: SPECT, PET, and MRI

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, FRG-69120 Heidelberg, Germany, Uwe_Haberkorn{at}med.uni-heidelberg.de

Annette Altmann

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, FRG-69120 Heidelberg, Germany

Gene therapy by the transfer and expression of suicide genes is performed using genes coding for nonmammalian enzymes that transform nontoxic prodrugs into toxic metabolites. Employing radiolabeled specific substrates and scintigraphic procedures to determine the functional activity of the recombinant enzyme in vivo, a therapeutic window of maximal gene expression and consecutive drug administration may be defined. If the gene therapy approach is based on the transduction of receptor genes, the recombinant gene expression in tumor cells can be monitored with radiolabeled ligands. Transfer of transporter genes as the sodium iodide transporter may also lead to the visualization of transduction via accumulation of iodide or pertechnetate. Furthermore, imaging based on transchelation of oxotechnetate to a polypeptide motif from a biocompatible complex with a higher dissociation constant than that of a diglycilcysteine complex or tyrosinase gene transfer for metal ion scavenging have been described. In addition, therapy effects may be assessed by the evaluation of the morphological changes of the tumor using magnetic resonance imaging or, more effectively, by the measurement of changes in metabolism with positron emission tomography employing tracers of tumor metabolism and proliferation. Finally, enzyme or receptor genes may serve as noninvasive reporter genes, if applied in the context of bicistronic vectors leading to coexpression of the therapeutic gene and the noninvasive reporter gene.

Key Words: gene therapy • cancer • suicide genes • MRI • PET • SPECT

Journal of Pharmacy Practice, Vol. 14, No. 5, 383-396 (2001)
DOI: 10.1106/EQAT-DEQG-6HR6-11H3


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?